ESSEX BIO-TECH unveils AGM agenda: HK$0.07 final dividend, 20% share issue mandate, 10% buy-back authority

Bulletin Express03-31

ESSEX BIO-TECH has released its 2026 AGM circular outlining key resolutions to be tabled on 26 May 2026 in Hong Kong.

Dividend • Board proposes a cash final dividend of HK$0.07 per share for FY 2025, payable on 12 June 2026. • Share transfer books will close from 1 – 3 June 2026; record date is 3 June 2026.

Capital mandates • Share issue mandate: Directors seek authority to issue up to 20% of issued share capital, equivalent to 113.40 million shares based on the 567.01 million shares outstanding as at 27 March 2026. • Share repurchase mandate: Company requests authority to buy back up to 10% of shares in issue, or 56.70 million shares. • Extension mandate: Any shares repurchased may be added to the issue mandate, effectively allowing a further 10% issue capacity.

Director elections and tenure • Executive Director Fang Haizhou and Independent Non-Executive Directors Fung Chi Ying and Yan Man Sing Frankie stand for re-election. • Fung Chi Ying and fellow INED Yeow Mee Mooi have served 24 years and 21 years respectively; the Board affirms their continued independence.

Other resolutions • Adoption of FY 2025 audited financial statements. • Re-appointment of BDO Limited as external auditor.

Key dates • AGM register closure: 20 – 26 May 2026; record date 26 May 2026. • Proxy forms due 48 hours before the AGM.

The Board states it has no immediate plans to issue or repurchase shares under the proposed mandates.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1195907302?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-31 16:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1195907302","market":"hk","top_or_hot":-1,"title":"ESSEX BIO-TECH unveils AGM agenda: HK$0.07 final dividend, 20% share issue mandate, 10% buy-back authority","media":"Bulletin Express","content":"<p>ESSEX BIO-TECH has released its 2026 AGM circular outlining key resolutions to be tabled on 26 May 2026 in Hong Kong.</p>\n<p>Dividend  \n• Board proposes a cash final dividend of HK$0.07 per share for FY 2025, payable on 12 June 2026.  \n• Share transfer books will close from 1 – 3 June 2026; record date is 3 June 2026.</p>\n<p>Capital mandates  \n• Share issue mandate: Directors seek authority to issue up to 20% of issued share capital, equivalent to 113.40 million shares based on the 567.01 million shares outstanding as at 27 March 2026.  \n• Share repurchase mandate: Company requests authority to buy back up to 10% of shares in issue, or 56.70 million shares.  \n• Extension mandate: Any shares repurchased may be added to the issue mandate, effectively allowing a further 10% issue capacity.</p>\n<p>Director elections and tenure  \n• Executive Director Fang Haizhou and Independent Non-Executive Directors Fung Chi Ying and Yan Man Sing Frankie stand for re-election.  \n• Fung Chi Ying and fellow INED Yeow Mee Mooi have served 24 years and 21 years respectively; the Board affirms their continued independence.</p>\n<p>Other resolutions  \n• Adoption of FY 2025 audited financial statements.  \n• Re-appointment of BDO Limited as external auditor.</p>\n<p>Key dates  \n• AGM register closure: 20 – 26 May 2026; record date 26 May 2026.  \n• Proxy forms due 48 hours before the AGM.</p>\n<p>The Board states it has no immediate plans to issue or repurchase shares under the proposed mandates.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ESSEX BIO-TECH unveils AGM agenda: HK$0.07 final dividend, 20% share issue mandate, 10% buy-back authority</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nESSEX BIO-TECH unveils AGM agenda: HK$0.07 final dividend, 20% share issue mandate, 10% buy-back authority\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-31 16:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>ESSEX BIO-TECH has released its 2026 AGM circular outlining key resolutions to be tabled on 26 May 2026 in Hong Kong.</p>\n<p>Dividend  \n• Board proposes a cash final dividend of HK$0.07 per share for FY 2025, payable on 12 June 2026.  \n• Share transfer books will close from 1 – 3 June 2026; record date is 3 June 2026.</p>\n<p>Capital mandates  \n• Share issue mandate: Directors seek authority to issue up to 20% of issued share capital, equivalent to 113.40 million shares based on the 567.01 million shares outstanding as at 27 March 2026.  \n• Share repurchase mandate: Company requests authority to buy back up to 10% of shares in issue, or 56.70 million shares.  \n• Extension mandate: Any shares repurchased may be added to the issue mandate, effectively allowing a further 10% issue capacity.</p>\n<p>Director elections and tenure  \n• Executive Director Fang Haizhou and Independent Non-Executive Directors Fung Chi Ying and Yan Man Sing Frankie stand for re-election.  \n• Fung Chi Ying and fellow INED Yeow Mee Mooi have served 24 years and 21 years respectively; the Board affirms their continued independence.</p>\n<p>Other resolutions  \n• Adoption of FY 2025 audited financial statements.  \n• Re-appointment of BDO Limited as external auditor.</p>\n<p>Key dates  \n• AGM register closure: 20 – 26 May 2026; record date 26 May 2026.  \n• Proxy forms due 48 hours before the AGM.</p>\n<p>The Board states it has no immediate plans to issue or repurchase shares under the proposed mandates.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01061","symbol_name":"亿胜生物科技","start_time":0,"source_url":"","article_id":"1195907302","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1195907302","pubTimestamp":1774946831,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"ESSEX BIO-TECH has released its 2026 AGM circular outlining key resolutions to be tabled on 26 May 2026 in Hong Kong. Dividend   • Board proposes a cash final dividend of HK$0.07 per share for FY...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01061":"亿胜生物科技"},"translate_title":"亿胜生物公布股东周年大会议程：末期股息0.07港元、20%股份发行授权、10%回购授权","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01061":1},"content_text":"ESSEX BIO-TECH has released its 2026 AGM circular outlining key resolutions to be tabled on 26 May 2026 in Hong Kong.\nDividend  \n• Board proposes a cash final dividend of HK$0.07 per share for FY 2025, payable on 12 June 2026.  \n• Share transfer books will close from 1 – 3 June 2026; record date is 3 June 2026.\nCapital mandates  \n• Share issue mandate: Directors seek authority to issue up to 20% of issued share capital, equivalent to 113.40 million shares based on the 567.01 million shares outstanding as at 27 March 2026.  \n• Share repurchase mandate: Company requests authority to buy back up to 10% of shares in issue, or 56.70 million shares.  \n• Extension mandate: Any shares repurchased may be added to the issue mandate, effectively allowing a further 10% issue capacity.\nDirector elections and tenure  \n• Executive Director Fang Haizhou and Independent Non-Executive Directors Fung Chi Ying and Yan Man Sing Frankie stand for re-election.  \n• Fung Chi Ying and fellow INED Yeow Mee Mooi have served 24 years and 21 years respectively; the Board affirms their continued independence.\nOther resolutions  \n• Adoption of FY 2025 audited financial statements.  \n• Re-appointment of BDO Limited as external auditor.\nKey dates  \n• AGM register closure: 20 – 26 May 2026; record date 26 May 2026.  \n• Proxy forms due 48 hours before the AGM.\nThe Board states it has no immediate plans to issue or repurchase shares under the proposed mandates.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1195907302","isCrawlerRequest":true}